SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Torben Noerup Nielsen who wrote (14931)2/12/1998 8:30:00 PM
From: Henry Niman  Read Replies (2) | Respond to of 32384
 
Torben. LGND has about 100 targets (75 in IRs and 25 in STATs) that address almost every pathological condition known. In addition to the receptors and ligands, they are looking at additional regulatory proteins that influence which genes are turned on where and under what conditions. I expect the basic research side to continue moving forward with breathtaking speed.



To: Torben Noerup Nielsen who wrote (14931)2/12/1998 8:59:00 PM
From: Andrew H  Respond to of 32384
 
>I think we can predict the ongoing nature of such unexpected
>discoveries.

>>I have to take exception to that part of your statement<<

>>I am waiting for discoveries. And while the exact discovery may be unexpected, the fact that there will be discoveries is not.<<

A fine point, Torben. I probably could have expressed myself more precisely, but that is just what I was trying to say.

Enjoyed your post.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News